1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. News
  7. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Real-time Estimate Tradegate  -  05/23 10:04:31 am EDT
17.28 EUR   +3.51%
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SYNLAB : Barclays reaffirms its Neutral rating

11/10/2021 | 06:01am EDT

Hassan Al-Wakeel from Barclays retains his Neutral opinion on the stock. The target price remains unchanged at EUR 21.


© MarketScreener with dpa-AFX Analyser 2021
All news about SYNLAB AG
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10SYNLAB AG : SYNLAB Medical Congress: making healthcare future-proof with advanced diagnost..
EQ
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Financials
Sales 2022 3 163 M 3 337 M 3 337 M
Net income 2022 309 M 326 M 326 M
Net Debt 2022 1 508 M 1 591 M 1 591 M
P/E ratio 2022 11,7x
Yield 2022 1,82%
Capitalization 3 709 M 3 913 M 3 913 M
EV / Sales 2022 1,65x
EV / Sales 2023 1,75x
Nbr of Employees 25 750
Free-Float 75,7%
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 16,69 €
Average target price 22,49 €
Spread / Average Target 34,7%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer
David Raymond Ebsworth Chairman-Supervisory Board
Santiago Valor Garcia Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNLAB AG-28.68%3 913
SONIC HEALTHCARE LIMITED-21.79%12 176
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-25.73%5 757
DIAGNOSTICOS DA AMÉRICA S.A.-43.72%2 186
DR. LAL PATHLABS LIMITED-48.59%2 087
HEALIUS LIMITED-20.08%1 706